Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NCEH1 | Q6PIU2 | 11/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9654427 | 0.91 | MAPT (0.55) | WDR5MAPTNCEH1LMNAKDM4E | |
| SCHEMBL27994957 | 0.87 | NCEH1 (0.48) | WDR5MAPTNCEH1LMNAKDM4E | |
| SCHEMBL9138037 | 0.83 | GSK3B (0.47) | WDR5MAPTNCEH1KDM4EALDH1A1 | |
| SCHEMBL28784940 | 0.82 | SLC6A9 (0.42) | KDM4EALDH1A1HPGDTDP1 | |
| SCHEMBL1156688 | 0.81 | ALDH1A1 (0.43) | MAPTKDM4EALDH1A1HPGDTDP1 | |
| SCHEMBL28784943 | 0.81 | PPARG (0.42) | MAPTTDP1 | |
| SCHEMBL28365601 | 0.80 | MAPT (0.53) | WDR5MAPTLMNAALOX5ALDH1A1 | |
| SCHEMBL10752267 | 0.79 | WDR5 (0.40) | WDR5MAPTNCEH1LMNAALOX5 | |
| SCHEMBL10752270 | 0.79 | WDR5 (0.40) | WDR5MAPTNCEH1LMNAALOX5 | |
| SCHEMBL7761409 | 0.79 | LDHA (0.55) | WDR5NCEH1LMNALDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4853361-A | FLUORAN-TYPE LEUCO DYES | JUJO PAPER CO., LTD. (JP) | 1989-08-01 | — | — | US | disclosed |